ENTA EBITDA Growth
Enanta Pharmaceuticals Inc · EBITDA Growth
ENTA EBITDA Growth
Year-over-year change vs the same period a year earlier
Latest reported45.02%period ending
ENTA TTM EBITDA YoY % (-52.85% → 45.02%)
Year-over-year change
High-resolution chart · PNG
ENTA ebitda growth history
Trailing twelve months (TTM). Each value covers four complete reported quarters.
| Period ending | EBITDA Growth |
|---|---|
| 45.0231% | |
| 46.5604% | |
| 37.4842% | |
| 31.7954% | |
| 20.8218% | |
| 25.0123% | |
| 24.4106% | |
| 15.3585% | |
| 15.6936% | |
| 5.3124% | |
| -5.5106% | |
| -3.5429% | |
| 2.1417% | |
| 3.6296% | |
| 4.0686% | |
| -13.0695% | |
| -37.4996% | |
| -56.9762% | |
| -95.2752% | |
| -177.5813% | |
| -677.6337% | |
| -648.8529% | |
| -350.4379% | |
| -194.997% | |
| -117.406% | |
| -82.9057% | |
| -75.8327% | |
| -55.9738% | |
| -38.7053% | |
| 15.6937% | |
| 116.3297% | |
| 232.9278% | |
| 471.9378% | |
| 519.4812% | |
| 638.3449% | |
| -17.272% | |
| -176.1941% | |
| -142.8719% | |
| -109.9202% | |
| -73.5678% | |
| -66.2694% | |
| -72.0801% | |
| -4.8411% | |
| 547.9749% | |
| 482.9537% | |
| 872.868% | |
| 633.0209% | |
| 101.3172% | |
| 94.9317% | |
| -277.7511% | |
| -138.1751% | |
| -55.6534% | |
| -52.8526% |